Results 111 to 120 of about 1,649 (190)
Candida species: the silent enemy [PDF]
Candida species are known to cause serious infections in immunocompromised patients but uncommon cases have been reported in immunocompetent individuals regardless of the harmless co-existence of the fungi with the host.
Al-Laaeiby, A, Al-Saadoon, A.H., Ali, S
core +2 more sources
Pathogens of importance in lung disease—Implications of the WHO fungal priority pathogen list
Respirology, Volume 29, Issue 1, Page 21-23, January 2024.
Justin Beardsley
wiley +1 more source
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope [PDF]
Invasive Scedosporium spp. and Lomentospora prolificans infections are an emerging threat in immunocompromised and occasionally in healthy hosts. Scedosporium spp. is intrinsically resistant to most, L. prolificans to all the antifungal drugs currently
Aurbach U. +27 more
core +1 more source
Objectives: The incidence of severe filamentous fungal infections has increased over the past decade. Some of these filamentous fungi are resistant to available antifungals; it is thus urgent to find new compounds that are active against such life ...
Hanane Yousfi +4 more
doaj +1 more source
Isolasi Jamur Kapang dari Tanah [PDF]
Tanah merupakan habitat berbagai mikroorganisme termasuk jamur. Jamur yang hidup di tanah termasuk jamur patogen untuk manusia. Antara lain golongan dermatofita, Aspergillus, dan Mucorales.
Hani, Safira +4 more
core +2 more sources
Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis [PDF]
Cystic fibrosis (CF) is characterised by chronic airway infection with bacteria and fungi. Infections caused by Scedosporium/Lomentospora species can occur and are difficult to treat.
C. Brandt +15 more
core +4 more sources
Hope on the horizon: Novel fungal treatments in development [PDF]
The treatment of invasive fungal infections remains challenging due to limitations in currently available antifungal therapies including toxicity, interactions, restricted routes of administration, and drug resistance.
Coler-Reilly, Ariella +3 more
core +1 more source
Lomentospora prolificans-induced Invasive Fungal Sinusitis.
Kakuno, Shigeki +3 more
openaire +2 more sources
Clinical Mycology Today: Emerging challenges and opportunities [PDF]
The Mycoses Study Group Education and Research Consortium is a collective of clinicians, researchers, and educators with the common goal to advance awareness, diagnosis, and management of invasive fungal diseases.
Little, Jessica +7 more
core +2 more sources

